HempNewsBreaks – Algae Dynamics Corp. (ADYNF) Receives $250,000 Investment to Enhance Existing University Research Programs

Algae Dynamics (OTC: ADYNF), developer of unique health products infused with cannabis and algae oils, has received an investment of $250,000 from Teewinot Life Sciences Corporation, developer of biosynthetic cannabinoids. Algae Dynamics says it will use the funds for its research programs with The University of Waterloo and University of Western Ontario, as well as general administrative and compliance purposes.

“These funds will allow us to continue our important university research programs and provide resources to move forward at an accelerated pace. We believe this new relationship with Teewinot will provide strategic value that will provide long term benefits for all of our key stakeholders,” Algae Dynamics chairman and President Paul Ramsay stated in the news release.

To view the full press release, visit http://cnw.fm/6IIJm

About Algae Dynamics Corp.

Algae Dynamics Corp is engaged in the development of unique health products that utilize cannabis and algae oils. The company has engaged two Canadian Universities to provide research and to develop products that combine the significant health benefits of Omega-3s derived from algae oil and extracts from cannabis oil. Algae’s research is focused on the development of these oils for the potential reduction of certain types of cancer cells, and the use of cannabis derivatives for the development of novel pharmacotherapies for mental health. For more information, visit www.AlgaeDynamics.com

More from CannabisNewsBreaks

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net

Chris@HW

Share
Published by
Chris@HW

Recent Posts

HempNewsBreaks – Turning Point Brands Inc. (NYSE: TPB) Closes $300M Senior Secured Notes Offering 

Turning Point Brands (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, recently…

2 months ago

HempNewsBreaks – WEED Inc. (BUDZ) Announces 2024 Highlights, Plans to Expand into Consumer Packaged Goods

WEED Inc. (OTCQB: BUDZ), a global cannabis and hemp bioresearch company based in the U.S.,…

4 months ago

HempNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Closes $3.6M Registered Direct

Flora (NASDAQ: FLGC) has closed a registered direct offering to institutional investors for the aggregate…

5 months ago

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) to Host Spaces Event, Share Comprehensive Update on Destino Ranch

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced its plans to host a Spaces call…

5 months ago

HempNewsBreaks – CBD Life Sciences Inc. (CBDL) Poised to Become Game Changer in the Hemp Industry

CBD Life Sciences (OTC: CBDL) today announced its potential for explosive profits in a $70…

6 months ago

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Cleared to Begin Human Pilot Study #3 Evaluating DehydraTECH-Processed Tirzepatide

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, announced Friday that…

7 months ago